236 related articles for article (PubMed ID: 16636053)
61. Jembrana disease virus Vif antagonizes the inhibition of bovine APOBEC3 proteins through ubiquitin-mediate protein degradation.
Su X; Wang H; Zhou X; Li Z; Zheng B; Zhang W
Virology; 2018 Jun; 519():53-63. PubMed ID: 29653302
[TBL] [Abstract][Full Text] [Related]
62. HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction.
Gargan S; Ahmed S; Mahony R; Bannan C; Napoletano S; O'Farrelly C; Borrow P; Bergin C; Stevenson NJ
EBioMedicine; 2018 Apr; 30():203-216. PubMed ID: 29580840
[TBL] [Abstract][Full Text] [Related]
63. Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif.
Walker RC; Khan MA; Kao S; Goila-Gaur R; Miyagi E; Strebel K
J Virol; 2010 May; 84(10):5201-11. PubMed ID: 20219919
[TBL] [Abstract][Full Text] [Related]
64. Complementary function of the two catalytic domains of APOBEC3G.
Navarro F; Bollman B; Chen H; König R; Yu Q; Chiles K; Landau NR
Virology; 2005 Mar; 333(2):374-86. PubMed ID: 15721369
[TBL] [Abstract][Full Text] [Related]
65. HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation.
Santa-Marta M; da Silva FA; Fonseca AM; Goncalves J
J Biol Chem; 2005 Mar; 280(10):8765-75. PubMed ID: 15611076
[TBL] [Abstract][Full Text] [Related]
66. Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.
Zhang Z; Gu Q; Jaguva Vasudevan AA; Jeyaraj M; Schmidt S; Zielonka J; Perković M; Heckel JO; Cichutek K; Häussinger D; Smits SHJ; Münk C
J Virol; 2016 Nov; 90(22):10193-10208. PubMed ID: 27581978
[TBL] [Abstract][Full Text] [Related]
67. Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.
Gu Q; Zhang Z; Cano Ortiz L; Franco AC; Häussinger D; Münk C
J Virol; 2016 Dec; 90(23):10545-10557. PubMed ID: 27630243
[TBL] [Abstract][Full Text] [Related]
68. Structural basis of intersubunit recognition in elongin BC-cullin 5-SOCS box ubiquitin-protein ligase complexes.
Kim YK; Kwak MJ; Ku B; Suh HY; Joo K; Lee J; Jung JU; Oh BH
Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1587-97. PubMed ID: 23897481
[TBL] [Abstract][Full Text] [Related]
69. Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation.
DeHart JL; Bosque A; Harris RS; Planelles V
J Virol; 2008 Sep; 82(18):9265-72. PubMed ID: 18596088
[TBL] [Abstract][Full Text] [Related]
70. The interaction between HIV-1 Gag and APOBEC3G.
Cen S; Guo F; Niu M; Saadatmand J; Deflassieux J; Kleiman L
J Biol Chem; 2004 Aug; 279(32):33177-84. PubMed ID: 15159405
[TBL] [Abstract][Full Text] [Related]
71. HIV-1 Vif: HIV's weapon against the cellular defense factor APOBEC3G.
Kremer M; Schnierle BS
Curr HIV Res; 2005 Oct; 3(4):339-44. PubMed ID: 16250885
[TBL] [Abstract][Full Text] [Related]
72. Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.
Schröfelbauer B; Senger T; Manning G; Landau NR
J Virol; 2006 Jun; 80(12):5984-91. PubMed ID: 16731937
[TBL] [Abstract][Full Text] [Related]
73. Lineage-Specific Viral Hijacking of Non-canonical E3 Ubiquitin Ligase Cofactors in the Evolution of Vif Anti-APOBEC3 Activity.
Kane JR; Stanley DJ; Hultquist JF; Johnson JR; Mietrach N; Binning JM; Jónsson SR; Barelier S; Newton BW; Johnson TL; Franks-Skiba KE; Li M; Brown WL; Gunnarsson HI; Adalbjornsdóttir A; Fraser JS; Harris RS; Andrésdóttir V; Gross JD; Krogan NJ
Cell Rep; 2015 May; 11(8):1236-50. PubMed ID: 25981045
[TBL] [Abstract][Full Text] [Related]
74. Molecular architecture of the ankyrin SOCS box family of Cul5-dependent E3 ubiquitin ligases.
Muniz JR; Guo K; Kershaw NJ; Ayinampudi V; von Delft F; Babon JJ; Bullock AN
J Mol Biol; 2013 Sep; 425(17):3166-77. PubMed ID: 23806657
[TBL] [Abstract][Full Text] [Related]
75. Functional analysis and structural modeling of human APOBEC3G reveal the role of evolutionarily conserved elements in the inhibition of human immunodeficiency virus type 1 infection and Alu transposition.
Bulliard Y; Turelli P; Röhrig UF; Zoete V; Mangeat B; Michielin O; Trono D
J Virol; 2009 Dec; 83(23):12611-21. PubMed ID: 19776130
[TBL] [Abstract][Full Text] [Related]
76. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G.
Conticello SG; Harris RS; Neuberger MS
Curr Biol; 2003 Nov; 13(22):2009-13. PubMed ID: 14614829
[TBL] [Abstract][Full Text] [Related]
77. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.
Marin M; Rose KM; Kozak SL; Kabat D
Nat Med; 2003 Nov; 9(11):1398-403. PubMed ID: 14528301
[TBL] [Abstract][Full Text] [Related]
78. Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors.
Binning JM; Smith AM; Hultquist JF; Craik CS; Caretta Cartozo N; Campbell MG; Burton L; La Greca F; McGregor MJ; Ta HM; Bartholomeeusen K; Peterlin BM; Krogan NJ; Sevillano N; Cheng Y; Gross JD
PLoS Pathog; 2018 Jan; 14(1):e1006830. PubMed ID: 29304101
[TBL] [Abstract][Full Text] [Related]
79. HIV-2 Vif and foamy virus Bet antagonize APOBEC3B by different mechanisms.
Zhang Z; Perković M; Gu Q; Balakrishnan K; Sangwiman A; Häussinger D; Lindemann D; Münk C
Virology; 2021 Feb; 554():17-27. PubMed ID: 33333348
[TBL] [Abstract][Full Text] [Related]
80. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.
Newman EN; Holmes RK; Craig HM; Klein KC; Lingappa JR; Malim MH; Sheehy AM
Curr Biol; 2005 Jan; 15(2):166-70. PubMed ID: 15668174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
